血管新生緑内障の英語

なお、対象となる疾患の例は、糖尿病網膜症や血管新生緑内障等である。例文帳に追加

Examples of the target disorder include diabetic retinopathy, neovascular glaucoma and the like. - 特許庁

前記眼内血管新生性疾患としては、虚血性増殖性網膜症、黄斑浮腫、加齢性黄斑変性症、血管新生緑内障、角膜血管新生及び脈絡膜血管新生等が挙げられる。例文帳に追加

The intraocular neovascularization disease includes ischemic proliferative retinopathy, macular edema, age-related macular degeneration, neovascular glaucoma, corneal neovascularization, and choroidal neovascularization. - 特許庁

キマーゼ阻害作用を有するSuc-Val-Pro-HNCH(CH_2Ph)P(O)(OPh)_2は血管新生阻害作用を示し、血管新生が関与する疾患、特に糖尿病網膜症、黄斑変性症、網膜静脈閉塞症、未熟児網膜症、血管新生緑内障などの眼内血管新生性疾患の予防または治療剤として期待される。例文帳に追加

The Suc-Val-Pro-HNCH(CH_2Ph)P(O)(OPh)_2 having the chymase- inhibiting action exhibits neovascularization-inhibiting action and is expected as a prophylactic or therapeutic agent for diseases in which neovascularization involves, particularly, intraocular neovascular diseases such as diabetic retinopathy, maculopathy, retinal vein blockage, premature infant retinitis and neovascular glaucoma. - 特許庁

リマカリブまたはその薬学上許容される塩を有効成分として含有する、血管新生促進因子産生阻害剤、血管新生阻害剤、血管新生を伴う疾患の治療剤など（血管新生を伴う疾患としては、癌疾患、糖尿病網膜症、未熟児網膜症、加齢黄斑変性症、血管新生緑内障、慢性気管支炎、粥状動脈硬化症、心筋梗塞等があげられる）。例文帳に追加

This angiogenesis promoting factor production inhibitor, the angiogenesis inhibitor, and a therapeutic agent for diseases with angiogenesis (which include, for example, cancer diseases, diabetic retinopathy, retinopathy of prematurity, ageing macular degeneration, neovascular glaucoma, chronic bronchitis, atherosclerosis, and myocardial infarction) includes rimacalib or its pharmaceutically acceptable salt as an active ingredient. - 特許庁

加齢性黄斑変性症などの眼科疾患の治療及び予防だけでなく、緑内障、糖尿病性網膜症、脈絡膜新生血管膜、ブドウ膜炎、近視性変性、眼腫瘍、ルベオーシス眼新血管新生、ドライアイなどの眼病変の治療法を提供。例文帳に追加

To provide a method of treatment and/or prevention of ophthalmic diseases, such as age-related macular degeneration, but also other ocular pathologies such as glaucoma, diabetic retinopathy, choroidal neovascular membrane, uveitis, myopic degeneration, ocular tumors, rubeosis ocular neovascularization and dry eye. - 特許庁

異常ＣＴＧＦ発現を伴う眼障害には、緑内障、黄斑変性、糖尿病網膜症、脈絡膜血管新生、増殖性硝子体網膜症、及び創傷治癒が含まれる。例文帳に追加

Ocular disorders involving aberrant CTGF expression include glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing. - 特許庁

従って、癌、特に固形癌、血管腫などの腫瘍の増殖抑制に、慢性関節リューマチ、乾癬、強皮症、癌性腹水・胸水貯留などの疾病の予防・治療に、また、糖尿病性網膜症等の網膜疾患や血管新生緑内障などの眼疾患の予防・治療に有用である。例文帳に追加

Accordingly, the agent is useful for the suppression of the proliferation of cancer, especially tumors such as solid cancer and vascular neoplasm, the prevention/treatment of diseases such as chronic rheumatoid arthritis, psoriasis, scleroderma, and cancerous ascites/accumulation of pleural effusion, and the prevention/treatment of retinal diseases such as diabetic retinopathy and ophthalmic diseases such as neovascular glaucoma. - 特許庁